These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 21079424)

  • 1. Symptom and chest radiographic screening for infectious tuberculosis prior to starting isoniazid preventive therapy: yield and proportion missed at screening.
    Churchyard GJ; Fielding KL; Lewis JJ; Chihota VN; Hanifa Y; Grant AD
    AIDS; 2010 Nov; 24 Suppl 5():S19-27. PubMed ID: 21079424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse events with isoniazid preventive therapy: experience from a large trial.
    Grant AD; Mngadi KT; van Halsema CL; Luttig MM; Fielding KL; Churchyard GJ
    AIDS; 2010 Nov; 24 Suppl 5():S29-36. PubMed ID: 21079425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The timing of tuberculosis after isoniazid preventive therapy among gold miners in South Africa: a prospective cohort study.
    Hermans SM; Grant AD; Chihota V; Lewis JJ; Vynnycky E; Churchyard GJ; Fielding KL
    BMC Med; 2016 Mar; 14():45. PubMed ID: 27004413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary tuberculosis screening in anti-retroviral treated adults living with HIV in Kenya.
    Gersh JK; Barnabas RV; Matemo D; Kinuthia J; Feldman Z; Lacourse SM; Mecha J; Warr AJ; Kamene M; Horne DJ
    BMC Infect Dis; 2021 Feb; 21(1):218. PubMed ID: 33632173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tuberculosis outcomes and drug susceptibility in individuals exposed to isoniazid preventive therapy in a high HIV prevalence setting.
    van Halsema CL; Fielding KL; Chihota VN; Russell EC; Lewis JJ; Churchyard GJ; Grant AD
    AIDS; 2010 Apr; 24(7):1051-5. PubMed ID: 20299958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eligibility for isoniazid preventive therapy in South African gold mines.
    Lewis JJ; Fielding KL; Grant AD; Chihota VN; Popane F; Luttig M; Muller D; Coetzee L; Churchyard GJ
    PLoS One; 2013; 8(11):e81376. PubMed ID: 24244741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the Isoniazid Preventive Therapy Care Cascade Among HIV-Positive Female Sex Workers in Mombasa, Kenya.
    LaCourse SM; Deya RW; Graham SM; Masese LN; Jaoko W; Mandaliya KN; Overbaugh J; McClelland RS
    J Acquir Immune Defic Syndr; 2017 Sep; 76(1):74-81. PubMed ID: 28797022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial.
    Rangaka MX; Wilkinson RJ; Boulle A; Glynn JR; Fielding K; van Cutsem G; Wilkinson KA; Goliath R; Mathee S; Goemaere E; Maartens G
    Lancet; 2014 Aug; 384(9944):682-90. PubMed ID: 24835842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort.
    Golub JE; Pronyk P; Mohapi L; Thsabangu N; Moshabela M; Struthers H; Gray GE; McIntyre JA; Chaisson RE; Martinson NA
    AIDS; 2009 Mar; 23(5):631-6. PubMed ID: 19525621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for tuberculosis prior to isoniazid preventive therapy among HIV-infected gold miners in South Africa.
    Day JH; Charalambous S; Fielding KL; Hayes RJ; Churchyard GJ; Grant AD
    Int J Tuberc Lung Dis; 2006 May; 10(5):523-9. PubMed ID: 16704034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of alcohol use among people living with HIV initiating isoniazid preventive therapy in Ethiopia.
    Mukherjee TI; Hirsch-Moverman Y; Saito S; Gadisa T; Melaku Z; Howard AA
    Drug Alcohol Depend; 2019 Nov; 204():107465. PubMed ID: 31499239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.
    ; Danel C; Moh R; Gabillard D; Badje A; Le Carrou J; Ouassa T; Ouattara E; Anzian A; Ntakpé JB; Minga A; Kouame GM; Bouhoussou F; Emieme A; Kouamé A; Inwoley A; Toni TD; Ahiboh H; Kabran M; Rabe C; Sidibé B; Nzunetu G; Konan R; Gnokoro J; Gouesse P; Messou E; Dohoun L; Kamagate S; Yao A; Amon S; Kouame AB; Koua A; Kouamé E; Ndri Y; Ba-Gomis O; Daligou M; Ackoundzé S; Hawerlander D; Ani A; Dembélé F; Koné F; Guéhi C; Kanga C; Koule S; Séri J; Oyebi M; Mbakop N; Makaila O; Babatunde C; Babatounde N; Bleoué G; Tchoutedjem M; Kouadio AC; Sena G; Yededji SY; Assi R; Bakayoko A; Mahassadi A; Attia A; Oussou A; Mobio M; Bamba D; Koman M; Horo A; Deschamps N; Chenal H; Sassan-Morokro M; Konate S; Aka K; Aoussi E; Journot V; Nchot C; Karcher S; Chaix ML; Rouzioux C; Sow PS; Perronne C; Girard PM; Menan H; Bissagnene E; Kadio A; Ettiegne-Traore V; Moh-Semdé C; Kouame A; Massumbuko JM; Chêne G; Dosso M; Domoua SK; N'Dri-Yoman T; Salamon R; Eholié SP; Anglaret X
    N Engl J Med; 2015 Aug; 373(9):808-22. PubMed ID: 26193126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of isoniazid preventive therapy among people living with HIV in Kenya: A retrospective study of routine health care data.
    Karanja M; Kingwara L; Owiti P; Kirui E; Ngari F; Kiplimo R; Maina M; Masini E; Onyango E; Ngugi C
    PLoS One; 2020; 15(12):e0234588. PubMed ID: 33264300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contact evaluation and isoniazid preventive therapy among close and household contacts of tuberculosis patients in Lima, Peru: an analysis of routine data.
    Otero L; Battaglioli T; Ríos J; De la Torre Z; Trocones N; Ordoñez C; Seas C; Van der Stuyft P
    Trop Med Int Health; 2020 Mar; 25(3):346-356. PubMed ID: 31758837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tuberculosis among adults starting antiretroviral therapy in South Africa: the need for routine case finding.
    Hanifa Y; Fielding KL; Charalambous S; Variava E; Luke B; Churchyard GJ; Grant AD
    Int J Tuberc Lung Dis; 2012 Sep; 16(9):1252-9. PubMed ID: 22794030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the intensified tuberculosis case finding guidelines for children living with HIV.
    Sawry S; Moultrie H; Van Rie A
    Int J Tuberc Lung Dis; 2018 Nov; 22(11):1322-1328. PubMed ID: 30355412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of chest radiography in a tuberculosis prevention programme for HIV-infected people, Botswana.
    Mosimaneotsile B; Talbot EA; Moeti TL; Hone NM; Moalosi G; Moffat HJ; Lee EJ; Kenyon TA
    Lancet; 2003 Nov; 362(9395):1551-2. PubMed ID: 14615113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for active tuberculosis before isoniazid preventive therapy among HIV-infected West African adults.
    Moh R; Badjé A; N'takpé JB; Kouamé GM; Gabillard D; Ouassa T; Ouattara E; Le Carrou J; Bohoussou F; Messou E; Eholié S; Anglaret X; Danel C
    Int J Tuberc Lung Dis; 2017 Dec; 21(12):1237-1244. PubMed ID: 29297443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful implementation of isoniazid preventive therapy at a pediatric HIV clinic in Tanzania.
    Hunter OF; Kyesi F; Ahluwalia AK; Daffé ZN; Munseri P; von Reyn CF; Adams LV
    BMC Infect Dis; 2020 Oct; 20(1):738. PubMed ID: 33028260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: individual participant data meta-analysis of observational studies.
    Getahun H; Kittikraisak W; Heilig CM; Corbett EL; Ayles H; Cain KP; Grant AD; Churchyard GJ; Kimerling M; Shah S; Lawn SD; Wood R; Maartens G; Granich R; Date AA; Varma JK
    PLoS Med; 2011 Jan; 8(1):e1000391. PubMed ID: 21267059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.